News

: AstraZeneca reveals COVID-19 vaccine sales but that isn’t why the stock is rising

0

AstraZeneca stock jumped 3.4% in early trading on Friday, as the U.K.-Swedish drug company reported better-than-expected earnings, led by its blockbuster cancer drugs.

MarketWatch Premium: Wary of buying international stocks? At least you no longer need to worry about hedging

Previous article

: Apple hit with landmark antitrust charges in Europe over App Store practices

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News